CN Patent

CN108619525B — 奈妥吡坦-mPEG-PLA纳米粒及其制备方法和用途

Assigned to Individual · Expires 2020-12-29 · 5y expired

What this patent protects

本发明属于医药领域，具体涉及奈妥吡坦‑mPEG‑PLA纳米粒及其制备方法和用途。本发明所解决的技术问题是提供一种新型的方法来解决奈妥吡坦水溶性差的问题，利用两亲性mPEG‑PLA双嵌段聚合物来包裹奈妥吡坦，采用自组装的方法制备得到了一种奈妥吡坦‑mPEG‑PLA纳米粒。该奈妥吡坦‑mPEG‑PLA纳米粒具有水溶性好、粒度均匀、冻干可复溶、易吸收、可静脉注射等优点。

USPTO Abstract

本发明属于医药领域，具体涉及奈妥吡坦‑mPEG‑PLA纳米粒及其制备方法和用途。本发明所解决的技术问题是提供一种新型的方法来解决奈妥吡坦水溶性差的问题，利用两亲性mPEG‑PLA双嵌段聚合物来包裹奈妥吡坦，采用自组装的方法制备得到了一种奈妥吡坦‑mPEG‑PLA纳米粒。该奈妥吡坦‑mPEG‑PLA纳米粒具有水溶性好、粒度均匀、冻干可复溶、易吸收、可静脉注射等优点。

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN108619525B
Jurisdiction: CN
Classification: —
Expires: 2020-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.